These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15232333)
1. Alprazolam attenuates the behavioral effects of d-amphetamine in humans. Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333 [TBL] [Abstract][Full Text] [Related]
2. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353 [TBL] [Abstract][Full Text] [Related]
3. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Marks KR; Lile JA; Stoops WW; Rush CR Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531 [TBL] [Abstract][Full Text] [Related]
4. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine. Stoops WW Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868 [TBL] [Abstract][Full Text] [Related]
5. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473 [TBL] [Abstract][Full Text] [Related]
6. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. Rush CR; Stoops WW; Hays LR; Glaser PE; Hays LS J Pharmacol Exp Ther; 2003 Jul; 306(1):195-204. PubMed ID: 12676890 [TBL] [Abstract][Full Text] [Related]
7. Similar discriminative-stimulus effects of D-amphetamine in women and men. Vansickel AR; Lile JA; Stoops WW; Rush CR Pharmacol Biochem Behav; 2007; 87(2):289-96. PubMed ID: 17561238 [TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Stoops WW; Lile JA; Glaser PE; Rush CR Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504 [TBL] [Abstract][Full Text] [Related]
9. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Rush CR; Kollins SH; Pazzaglia PJ Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144 [TBL] [Abstract][Full Text] [Related]
10. Differential modulation of the discriminative stimulus effects of methamphetamine and cocaine by alprazolam and oxazepam in male and female rats. Spence AL; Guerin GF; Goeders NE Neuropharmacology; 2016 Mar; 102():146-57. PubMed ID: 26541330 [TBL] [Abstract][Full Text] [Related]
11. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans. Kollins SH; Rush CR Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Heishman SJ; Henningfield JE Psychopharmacology (Berl); 1991; 103(4):436-42. PubMed ID: 2062984 [TBL] [Abstract][Full Text] [Related]
14. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935 [TBL] [Abstract][Full Text] [Related]
15. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121 [TBL] [Abstract][Full Text] [Related]
16. Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo. Smith BJ; Bickel WK Drug Alcohol Depend; 2001 Feb; 61(3):249-60. PubMed ID: 11164689 [TBL] [Abstract][Full Text] [Related]
17. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats. Dukat M; Wesolowska A; Young R; Glennon RA Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. Sevak RJ; Stoops WW; Hays LR; Rush CR J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030 [TBL] [Abstract][Full Text] [Related]
19. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine. Negus SS; Gatch MB; Mello NK Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446 [TBL] [Abstract][Full Text] [Related]
20. mu-, delta- and kappa-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats. Woolfolk DR; Holtzman SG Drug Alcohol Depend; 1997 Dec; 48(3):209-20. PubMed ID: 9449020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]